Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant

B Labar; V Bogdanić; D Nemet; J Kovacević-Metelko; M Mrsić; Z Pavletić; S Zupancić-Salek; I Radman; I Aurer

Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant

Bone Marrow Transplant. 1992 Nov;10(5):471-2.

Authors

B Labar¹, V Bogdanić, D Nemet, J Kovacević-Metelko, M Mrsić, Z Pavletić, S Zupancić-Salek, I Radman, I Aurer

Affiliation

¹ Department of Internal Medicine, School of Medicine, University of Zagreb, Croatia.

PMID: 1464014

Abstract

A patient developed pure red cell aplasia after ABO incompatible BMT for leukemia. He did not respond to plasma exchange. Antilymphocyte globulin therapy was followed by complete and permanent erythroid recovery with disappearance of recipient-derived isoagglutinins.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

ABO Blood-Group System*
Adult
Antilymphocyte Serum / therapeutic use*
Blood Group Incompatibility / etiology*
Bone Marrow Transplantation / adverse effects*
Humans
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
Red-Cell Aplasia, Pure / drug therapy*
Red-Cell Aplasia, Pure / etiology

Substances

ABO Blood-Group System
Antilymphocyte Serum